Skip to main content

Table 3 Incidence and characteristics of acute-onset endophthalmitis after 25-gauge pars plana vitrectomy

From: Endophthalmitis after pars plana vitrectomy with reused single-use devices: a 13-year retrospective study

Study (year) Present study (2019) Lihteh et al. [26] Oshima et al. [2] Chen et al. [22] Scott et al. [17] Shimada et al. [20] Kunimoto et al. [21]
Period of study (number of years) 2005–2017 (13) 2005–2009 (5) 2003–2008 (6) 2002–2006 (5) 2005–2006 (2) 2004–2007 (4) 2004–2006 (3)
No. of cases per patients (incidence rate) 2/1089 (0.18) 1/4717 (0.02) 6/8238 (0.07) 1/431 (0.23) 11/1307 (0.84) 1/3343 (0.03) 7/3103 (0.23)
No. of cases with postoperative hypotony (%) 0 NA 1/6 (17) 0 NA 0 0
Intraoperative injections (number of infected eyes receiving injections) 0 0 NA SC DEX (1/1) SC cefazolin (9/11) SC tobramycin and DEX (1/1) Gentamicin in infusion fluid (7/7)
Median onset of endophthalmitis (days) 9 (5–13) 5 2 (1–3) 7 3 (1–15) 1 2 (2–10)
No. of cases with culture-positive (%) 0/2 (0) 0/1 (0) 3/6 (50) 0/1 (0) 7/11 (63) 1/1 (100) NA
Causative Microorganisms (%) MRSE (67) CNS (86) ES NA
  1. NA not available, SC subconjunctival, DEX dexamethasone, ES Enterococcus faecalis, CNS coagulase-negative staphylococcus, MRSE methicillin-resistant Staphylococcus epidermis